Flavonoids in the treatment of Leishmania amazonensis: a review of efficacy and mechanisms
Frontiers in Pharmacology · 07.08.2025 · 16
DOI: 10.3389/fphar.2025.1642005 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 07.08.2025. Verfasst von Vinicius Lopes Lessa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba, Paraná, Brazil. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Leishmaniasis is caused by protozoan parasites of the genus Leishmania . In recent years, natural compounds have attracted significant interest due to their potential efficacy and lower toxicity compared to synthetic chemical compounds. This review analyzed studies retrieved from the PubMed and Google Scholar databases, focusing on the use of flavonoids against Leishmania amazonensis . Only studies testing flavonoids with known activity against the parasite were included and categorized according to their leishmanicidal efficacy. Based on the criteria established to identify the most comprehensive studies, 52 were included in the analysis. Of these, three studies met at least 13 of the evaluation parameters (70%) and were considered the most complete. Analysis of IC 50 values reported in these articles revealed the activity of 69 flavonoids. Among the assays on amastigote forms, 33 reported high activity, and six reported moderate activity. For assays on promastigote forms, 32 experiments reported high activity, 16 showed moderate activity, and two demonstrated weak activity. Of the flavonoids tested, morelloflavone-4‴O-β-D-glycosyl and pinostrobin showed the highest activity, while naringenin exhibited the weakest activity, specifically against promastigote forms. In the cytotoxicity assays, carajurin and luteolin exhibited the highest selectivity indices reported in the articles. This review emphasizes the importance of studying flavonoids, particularly those extracted from plants and propolis, to advance our understanding and treatment of L. amazonensis infections.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba, Paraná, Brazil.
- Graduate Program in Veterinary Sciences, Federal University of Paraná, Curitiba, Paraná, Brazil.
- Graduate Nursing Progam, Campos de Andrade University Center, Curitiba, Paraná, Brazil.
- Department of Epidemiology and Community Health, College of Health and Human Services, University of North Carolina at Charlotte, Charlotte, NC, United States.
- Center for Computational Intelligence to Predict Health and Environmental Risks (CIPHER), University of North Carolina at Charlotte, Charlotte, NC, United States.
Zitieren
APA
Lessa, V. L., Drescher, G., Gonçalves, G., Lopes, J. C. B., Vieira, R. F. D. C., & Figueiredo, F. B. (2025). Flavonoids in the treatment of Leishmania amazonensis: a review of efficacy and mechanisms. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1642005
Vancouver
Lessa VL, Drescher G, Gonçalves G, Lopes JCB, Vieira RFDC, Figueiredo FB. Flavonoids in the treatment of Leishmania amazonensis: a review of efficacy and mechanisms. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1642005
BibTeX
@article{Lessa2025,
author = {Lessa, Vinicius Lopes and Drescher, Guilherme and Gonçalves, Gustavo and Lopes, João Carlos Baptista and Vieira, Rafael Felipe da Costa and Figueiredo, Fabiano Borges},
title = {Flavonoids in the treatment of Leishmania amazonensis: a review of efficacy and mechanisms},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1642005}
}
EUVIMED